Correspondence 0001683168-24-003258 from AETHLON MEDICAL INC (AEMD)
AETHLON MEDICAL INC
Date: May 10, 2024 · CIK: 0000882291 · Accession: 0001683168-24-003258
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-278188
Letter
Aethlon Medical, Inc.
11555 Sorrento Valley Road, Suite 203
San Diego, California 92121
May 10, 2024
Via Edgar
U.S. Securities and Exchange Commission
Division of Corporation Finance
100 F Street, N.E.
Washington, D.C. 20549
Attn: Robert Augustin
Re: Aethlon Medical, Inc.
Registration Statement on Form S-1, as amended (File No. 333-278188)
Acceleration Request
Requested Date: May 14, 2024
Requested Time: 9:00 A.M. Eastern Time
Ladies and Gentlemen:
Pursuant to Rule 461 under the Securities Act of 1933, as amended, Aethlon Medical, Inc. hereby requests that the U.S. Securities and Exchange Commission accelerate the effective date of the above-referenced Registration Statement on Form S-1, as amended (the “Registration Statement”), and declare the Registration Statement effective as of 9:00 A.M. Eastern Time on May 14, 2024, or as soon thereafter as practicable.
Once the Registration Statement has been declared effective, please orally confirm that event with Julie Robinson of Cooley LLP at (858) 550-6092, or in her absence, Wade Andrews of Cooley LLP at (858) 550-6042. Thank you for your assistance with this matter.
Sincerely,
Aethlon
medical, Inc.
Show Raw Text
CORRESP
1
filename1.htm
Aethlon Medical, Inc.
11555 Sorrento Valley Road, Suite 203
San Diego, California 92121
May 10, 2024
Via
Edgar
U.S. Securities and Exchange Commission
Division of Corporation Finance
100 F Street, N.E.
Washington, D.C. 20549
Attn: Robert Augustin
Re:
Aethlon Medical, Inc.
Registration Statement on Form S-1, as amended (File No. 333-278188)
Acceleration Request
Requested Date: May 14, 2024
Requested Time: 9:00 A.M. Eastern Time
Ladies and Gentlemen:
Pursuant to Rule 461 under the Securities Act
of 1933, as amended, Aethlon Medical, Inc. hereby requests that the U.S. Securities and Exchange Commission accelerate the effective date
of the above-referenced Registration Statement on Form S-1, as amended (the “Registration Statement”), and declare
the Registration Statement effective as of 9:00 A.M. Eastern Time on May 14, 2024, or as soon thereafter as practicable.
Once the Registration Statement has been declared
effective, please orally confirm that event with Julie Robinson of Cooley LLP at (858) 550-6092, or in her absence, Wade Andrews of Cooley
LLP at (858) 550-6042. Thank you for your assistance with this matter.
Sincerely,
Aethlon
medical, Inc.
/s/ James B. Frakes
James B. Frakes
Interim Chief Executive Officer and Chief Financial Officer